DSC

DSC

10,500
+0.00%
Mkt Cap 3.4T
Data as of 2026-07-23 · Source: public Vietnamese market feeds

By Aveluro Research Team · Editorial policy

DSC (DSC) is a company in Vietnam's Financial Services sector, listed on HOSE. The stock last traded at 10,500 VND, little changed on the session, giving a market capitalization of 3.4 trillion VND.

On valuation, DSC trades at a price-to-earnings ratio of 12.2 and a price-to-book of 1.1. That is a discount to the Financial Services sector average P/E of 31.9. Return on equity of 9.0% points to modest profitability relative to the company's equity base, above the sector average of 6.6%. Trailing earnings per share stand at 1,002 VND.

Aveluro tracks 4 news items mentioning DSC, where recent coverage skews positive (75% of articles). The most recent catalyst was a capital raise event — "Vidipha (VDP) Rights Offering: 10M Shares at 10,000 VND to Fund Cephalosporin Line". Aveluro's composite model rates DSC 6.1/10 (Hold), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Financial Services sector include AAS, ABW and AGR.

Latest price
10,500 VND · +0.00%
Dominant Sentiment
Positive · 4 Articles Analyzed
Latest catalyst
capital raise
Data as of
2026-07-23

Vidipha (VDP) Rights Offering: 10M Shares at 10,000 VND to Fund Cephalosporin Line

Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.

6.1
Hold
Sentiment
+0.00
Impact
0.50
Momentum
-1.00
Fundamentals
+0.20
Volume
1.00
P/E
12.2
P/B
1.1
ROE
9.0%
ROA
3.7%
EPS
1.0K
Articles Analyzed
4
Dominant Sentiment
Positive
Positive 3
Neutral 1
Full Analysis capital raise Jul 19, 2026
Vidipha (VDP) Rights Offering: 10M Shares at 10,000 VND to Fund Cephalosporin Line

Vidipha (VDP) will issue 9.94 million shares to existing shareholders at 10,000 VND/share, raising over 99.3 billion VND to invest in a Cephalosporin injection production line targeting EU-GMP standards. The rights offering, with a 100:45 ratio, will increase charter capital from 220.8 billion VND to 320.2 billion VND. Major shareholders including DSC and DVN are expected to participate.

5 Neutral
Read full analysis →
Full Analysis earnings beat Apr 22, 2026
DSC Securities Reports 39.4% Q1 Revenue Growth, Targets 2026 M&A in Pharma

DSC Securities reported Q1/2026 revenue of VND 184 billion, a 39.4% year-on-year increase, while pre-tax profit rose 7% to VND 72 billion. The company is actively pursuing a co-investment strategy with TC Group to acquire pharmaceutical firms, aiming for full-year revenue of VND 747 billion and targeting a return on equity above 10%.

8 +8.4 Positive
Read full analysis →
Full Analysis stake change Apr 18, 2026
Capella Group Becomes Major Shareholder in DNSE Securities (DSE) with 9.8% Stake

Capella Group becomes a major shareholder in DNSE Securities (DSE) with a 9.8% stake after acquiring 42.075 million shares through a rights issue that raised VND 1,275 billion. The move signals strategic alignment between Capella and DNSE, with Capella's technology director joining the board. Separately, an individual became a major shareholder in DSC Securities (DSC) via a similar rights offering in November 2025.

5 +5.0 Positive
Read full analysis →
Full Analysis guidance raise Apr 16, 2026
DSC Securities Targets Record Profit in 2026, Leverages TC Group Ecosystem

DSC Securities targets 2026 pre-tax profit of VND 356B (+3%) and revenue of VND 747B (+7%), both record highs, approved at its 2026 AGM. The plan emphasizes maximizing margin lending profitability and deepening client exploitation from the TC Group ecosystem.

6 +5.6 Positive
Read full analysis →

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-07-23T12:34:26Z.